baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

SINOPHARM GRP CO. H YC 1/ CNE100000FN7 /

2024-04-19 10:59:58 PM	Chg. +0.024	Volume	Bid10:59:58 PM	Ask10:59:58 PM	Market Capitalization	Dividend Y.	P/E Ratio
2.360EUR	+1.03%	- Turnover: -	2.360Bid Size: -	2.426Ask Size: -	3.26 bill.EUR	-	-

TeleTrader 2021-11-09 Sinopharm to test COVID drug in UAE, China

TeleTrader 2021-10-11 WHO recommends 3rd dose for over-60s after Sinovac, Sinopharm jab

TeleTrader 2021-06-11 China confirms Sinovac, Sinopharm shots approved for 3-17-y/os

TeleTrader 2021-04-10 Sinopharm's 3rd vaccine approved for clinical trials

TeleTrader 2021-03-15 Sinopharm, Sinovac researching effects of 3rd dose - report

TeleTrader 2021-02-28 Sinopharm Wuhan to make 100M vaccine doses per year

TeleTrader 2021-02-24 Sinopharm: 2nd vaccine 73% effective in trials

TeleTrader 2021-01-29 French official in favor of using Russia, China jabs

TeleTrader 2021-01-29 Hungary first in EU to approve Sinopharm's vaccine

TeleTrader 2021-01-20 Chinese vaccine makers applied to join COVAX - Beijing FM

TeleTrader 2021-01-03 Sinopharm, Sinovac deny vaccine smuggling claims

TeleTrader 2020-12-31 Sinopharm's COVID vaccine approved in China

TeleTrader 2020-11-25 Sinopharm seeks COVID vaccine authorization for public use

TeleTrader 2020-08-18 Sinopharm: Vaccine to be available by end of year

TeleTrader 2020-07-16 China's vaccine effective vs all COVID mutations - Sinopharm

TeleTrader 2020-06-28 Vaccine human trials were successful - China institute

TeleTrader 2020-06-23 China's COVID-19 vaccine to start phase 3 human trials

SINOPHARM GRP CO. H YC 1/ CNE100000FN7 /

If you wish to receive reply to your feedback, please provide your email address.